PrivateMarketView

Ascenta Capital's book

8 companies · priced for members

Company	Industry	Valuation	$/share	First invested	Role
Tubulis	Drug Discovery	▮	▮	▮	▮
Cardurion	Biotechnology	▮	▮	▮	▮
Iambic	—	▮	▮	▮	▮
+ 5 more companies · all 8, priced and dated or a free account shows the top 10 names — no card The whole book · Pro $99 a month Membership and data by Private Market View

Ascenta Capital portfolio at a glance

8 portfolio companies are on record for Ascenta Capital, including Tubulis, Cardurion and Iambic. The book leans Biotechnology (3), Drug Discovery (2) and Discovery Tools (Healthcare) (1).

6 of the 8 carry a recorded valuation.

Free account

See more of the book

·The top 10 names in the book — of 8 recorded positions
·Watchlist + alerts for Ascenta Capital's activity

Create free account

Membership and data by Private Market View

No card required